Summary

The global Ex Vivo Organ Perfusion market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Ex vivo organ perfusion is a technique used in transplantation and research to preserve and evaluate organs outside of the body before transplantation. During ex vivo perfusion, the organ is connected to a perfusion system that delivers oxygenated blood or a specialized preservation solution to maintain the organ's viability and function. This process allows for the assessment and optimization of organ function, as well as the potential for organ repair or treatment prior to transplantation. Ex vivo organ perfusion offers several advantages over traditional static cold storage, including the ability to assess organ viability, reduce ischemic injury, and potentially expand the donor pool by allowing for the use of marginal or extended criteria organs. Additionally, ex vivo perfusion enables researchers to study organ physiology, test new therapies, and improve transplantation outcomes.
In 2025, the North America Ex Vivo Organ Perfusion market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Ex Vivo Organ Perfusion include TransMedics, Lung Bioengineering, OrganOx, XVIVO, TNO, UHN, SCREEN, Bridge to Life, Organ Recovery Systems, Institut Georges Lopez, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Ex Vivo Organ Perfusion market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
TransMedics
Lung Bioengineering
OrganOx
XVIVO
TNO
UHN
SCREEN
Bridge to Life
Organ Recovery Systems
Institut Georges Lopez
Ebers
Penn Medicine
Johns Hopkins Medicine
Segment by Type
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion
Segment by Application
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Ex Vivo Organ Perfusion market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Ex Vivo Organ Perfusion value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Heart Perfusion
1.2.3 Liver Perfusion
1.2.4 Kidney Perfusion
1.2.5 Lung Perfusion
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Organ Transplant Specialist Hospitals
1.3.3 Organ Banks
1.3.4 Pharmaceutical Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Ex Vivo Organ Perfusion Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Ex Vivo Organ Perfusion Market Share by Revenue, by Region (2021-2026)
2.4 Global Ex Vivo Organ Perfusion Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Ex Vivo Organ Perfusion Market Size and Prospective (2021-2032)
2.5.2 Europe Ex Vivo Organ Perfusion Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Ex Vivo Organ Perfusion Market Size and Prospective (2021-2032)
2.5.4 Latin America Ex Vivo Organ Perfusion Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Ex Vivo Organ Perfusion Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Ex Vivo Organ Perfusion Historical Market Size by Type (2021-2026)
3.2 Global Ex Vivo Organ Perfusion Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Ex Vivo Organ Perfusion

4 Breakdown Data by Application
4.1 Global Ex Vivo Organ Perfusion Historical Market Size by Application (2021-2026)
4.2 Global Ex Vivo Organ Perfusion Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Ex Vivo Organ Perfusion Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Ex Vivo Organ Perfusion Players by Revenue (2021-2026)
5.1.2 Global Ex Vivo Organ Perfusion Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Ex Vivo Organ Perfusion Revenue
5.4 Global Ex Vivo Organ Perfusion Market Concentration Analysis
5.4.1 Global Ex Vivo Organ Perfusion Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Ex Vivo Organ Perfusion Revenue in 2025
5.5 Global Key Players of Ex Vivo Organ Perfusion Head Offices and Areas Served
5.6 Global Key Players of Ex Vivo Organ Perfusion, Product and Application
5.7 Global Key Players of Ex Vivo Organ Perfusion, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Ex Vivo Organ Perfusion Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.1.2.2 North America Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.1.3.2 North America Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
6.1.4 North America Ex Vivo Organ Perfusion Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Ex Vivo Organ Perfusion Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.2.2.2 Europe Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.2.3.2 Europe Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
6.2.4 Europe Ex Vivo Organ Perfusion Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Ex Vivo Organ Perfusion Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Ex Vivo Organ Perfusion Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Ex Vivo Organ Perfusion Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.4.2.2 Latin America Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.4.3.2 Latin America Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
6.4.4 Latin America Ex Vivo Organ Perfusion Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Ex Vivo Organ Perfusion Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Ex Vivo Organ Perfusion Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 TransMedics
7.1.1 TransMedics Company Details
7.1.2 TransMedics Business Overview
7.1.3 TransMedics Ex Vivo Organ Perfusion Introduction
7.1.4 TransMedics Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.1.5 TransMedics Recent Development
7.2 Lung Bioengineering
7.2.1 Lung Bioengineering Company Details
7.2.2 Lung Bioengineering Business Overview
7.2.3 Lung Bioengineering Ex Vivo Organ Perfusion Introduction
7.2.4 Lung Bioengineering Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.2.5 Lung Bioengineering Recent Development
7.3 OrganOx
7.3.1 OrganOx Company Details
7.3.2 OrganOx Business Overview
7.3.3 OrganOx Ex Vivo Organ Perfusion Introduction
7.3.4 OrganOx Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.3.5 OrganOx Recent Development
7.4 XVIVO
7.4.1 XVIVO Company Details
7.4.2 XVIVO Business Overview
7.4.3 XVIVO Ex Vivo Organ Perfusion Introduction
7.4.4 XVIVO Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.4.5 XVIVO Recent Development
7.5 TNO
7.5.1 TNO Company Details
7.5.2 TNO Business Overview
7.5.3 TNO Ex Vivo Organ Perfusion Introduction
7.5.4 TNO Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.5.5 TNO Recent Development
7.6 UHN
7.6.1 UHN Company Details
7.6.2 UHN Business Overview
7.6.3 UHN Ex Vivo Organ Perfusion Introduction
7.6.4 UHN Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.6.5 UHN Recent Development
7.7 SCREEN
7.7.1 SCREEN Company Details
7.7.2 SCREEN Business Overview
7.7.3 SCREEN Ex Vivo Organ Perfusion Introduction
7.7.4 SCREEN Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.7.5 SCREEN Recent Development
7.8 Bridge to Life
7.8.1 Bridge to Life Company Details
7.8.2 Bridge to Life Business Overview
7.8.3 Bridge to Life Ex Vivo Organ Perfusion Introduction
7.8.4 Bridge to Life Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.8.5 Bridge to Life Recent Development
7.9 Organ Recovery Systems
7.9.1 Organ Recovery Systems Company Details
7.9.2 Organ Recovery Systems Business Overview
7.9.3 Organ Recovery Systems Ex Vivo Organ Perfusion Introduction
7.9.4 Organ Recovery Systems Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.9.5 Organ Recovery Systems Recent Development
7.10 Institut Georges Lopez
7.10.1 Institut Georges Lopez Company Details
7.10.2 Institut Georges Lopez Business Overview
7.10.3 Institut Georges Lopez Ex Vivo Organ Perfusion Introduction
7.10.4 Institut Georges Lopez Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.10.5 Institut Georges Lopez Recent Development
7.11 Ebers
7.11.1 Ebers Company Details
7.11.2 Ebers Business Overview
7.11.3 Ebers Ex Vivo Organ Perfusion Introduction
7.11.4 Ebers Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.11.5 Ebers Recent Development
7.12 Penn Medicine
7.12.1 Penn Medicine Company Details
7.12.2 Penn Medicine Business Overview
7.12.3 Penn Medicine Ex Vivo Organ Perfusion Introduction
7.12.4 Penn Medicine Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.12.5 Penn Medicine Recent Development
7.13 Johns Hopkins Medicine
7.13.1 Johns Hopkins Medicine Company Details
7.13.2 Johns Hopkins Medicine Business Overview
7.13.3 Johns Hopkins Medicine Ex Vivo Organ Perfusion Introduction
7.13.4 Johns Hopkins Medicine Revenue in Ex Vivo Organ Perfusion Business (2021-2026)
7.13.5 Johns Hopkins Medicine Recent Development

8 Ex Vivo Organ Perfusion Market Dynamics
8.1 Ex Vivo Organ Perfusion Industry Trends
8.2 Ex Vivo Organ Perfusion Market Drivers
8.3 Ex Vivo Organ Perfusion Market Challenges
8.4 Ex Vivo Organ Perfusion Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Ex Vivo Organ Perfusion Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Ex Vivo Organ Perfusion Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Ex Vivo Organ Perfusion Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Ex Vivo Organ Perfusion Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Ex Vivo Organ Perfusion Revenue Share by Region (2021-2026)
Table 6. Global Ex Vivo Organ Perfusion Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Ex Vivo Organ Perfusion Revenue Share Forecast by Region (2027-2032)
Table 8. Global Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Ex Vivo Organ Perfusion Market Share by Revenue, by Type (2021-2026)
Table 10. Global Ex Vivo Organ Perfusion Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Ex Vivo Organ Perfusion Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Ex Vivo Organ Perfusion Market Share by Revenue, by Application (2021-2026)
Table 15. Global Ex Vivo Organ Perfusion Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Ex Vivo Organ Perfusion Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Ex Vivo Organ Perfusion Applications
Table 18. Global Ex Vivo Organ Perfusion Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Ex Vivo Organ Perfusion Market Share by Players (2021-2026)
Table 20. Global Top Ex Vivo Organ Perfusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ex Vivo Organ Perfusion as of 2025)
Table 21. Ranking of Global Top Ex Vivo Organ Perfusion Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Ex Vivo Organ Perfusion Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Ex Vivo Organ Perfusion, Headquarters and Area Served
Table 24. Global Key Players of Ex Vivo Organ Perfusion, Product and Application
Table 25. Global Key Players of Ex Vivo Organ Perfusion, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Ex Vivo Organ Perfusion Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Ex Vivo Organ Perfusion Market Share by Revenue, by Company (2021-2026)
Table 29. North America Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Ex Vivo Organ Perfusion Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Ex Vivo Organ Perfusion Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Ex Vivo Organ Perfusion Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Ex Vivo Organ Perfusion Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Ex Vivo Organ Perfusion Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Ex Vivo Organ Perfusion Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Ex Vivo Organ Perfusion Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Ex Vivo Organ Perfusion Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & (US$ Million)
Table 47. TransMedics Company Details
Table 48. TransMedics Business Overview
Table 49. TransMedics Ex Vivo Organ Perfusion Product
Table 50. TransMedics Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 51. TransMedics Recent Development
Table 52. Lung Bioengineering Company Details
Table 53. Lung Bioengineering Business Overview
Table 54. Lung Bioengineering Ex Vivo Organ Perfusion Product
Table 55. Lung Bioengineering Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 56. Lung Bioengineering Recent Development
Table 57. OrganOx Company Details
Table 58. OrganOx Business Overview
Table 59. OrganOx Ex Vivo Organ Perfusion Product
Table 60. OrganOx Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 61. OrganOx Recent Development
Table 62. XVIVO Company Details
Table 63. XVIVO Business Overview
Table 64. XVIVO Ex Vivo Organ Perfusion Product
Table 65. XVIVO Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 66. XVIVO Recent Development
Table 67. TNO Company Details
Table 68. TNO Business Overview
Table 69. TNO Ex Vivo Organ Perfusion Product
Table 70. TNO Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 71. TNO Recent Development
Table 72. UHN Company Details
Table 73. UHN Business Overview
Table 74. UHN Ex Vivo Organ Perfusion Product
Table 75. UHN Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 76. UHN Recent Development
Table 77. SCREEN Company Details
Table 78. SCREEN Business Overview
Table 79. SCREEN Ex Vivo Organ Perfusion Product
Table 80. SCREEN Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 81. SCREEN Recent Development
Table 82. Bridge to Life Company Details
Table 83. Bridge to Life Business Overview
Table 84. Bridge to Life Ex Vivo Organ Perfusion Product
Table 85. Bridge to Life Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 86. Bridge to Life Recent Development
Table 87. Organ Recovery Systems Company Details
Table 88. Organ Recovery Systems Business Overview
Table 89. Organ Recovery Systems Ex Vivo Organ Perfusion Product
Table 90. Organ Recovery Systems Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 91. Organ Recovery Systems Recent Development
Table 92. Institut Georges Lopez Company Details
Table 93. Institut Georges Lopez Business Overview
Table 94. Institut Georges Lopez Ex Vivo Organ Perfusion Product
Table 95. Institut Georges Lopez Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 96. Institut Georges Lopez Recent Development
Table 97. Ebers Company Details
Table 98. Ebers Business Overview
Table 99. Ebers Ex Vivo Organ Perfusion Product
Table 100. Ebers Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 101. Ebers Recent Development
Table 102. Penn Medicine Company Details
Table 103. Penn Medicine Business Overview
Table 104. Penn Medicine Ex Vivo Organ Perfusion Product
Table 105. Penn Medicine Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 106. Penn Medicine Recent Development
Table 107. Johns Hopkins Medicine Company Details
Table 108. Johns Hopkins Medicine Business Overview
Table 109. Johns Hopkins Medicine Ex Vivo Organ Perfusion Product
Table 110. Johns Hopkins Medicine Revenue in Ex Vivo Organ Perfusion Business (2021-2026) & (US$ Million)
Table 111. Johns Hopkins Medicine Recent Development
Table 112. Ex Vivo Organ Perfusion Market Trends
Table 113. Ex Vivo Organ Perfusion Market Drivers
Table 114. Ex Vivo Organ Perfusion Market Challenges
Table 115. Ex Vivo Organ Perfusion Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List of Figures
Figure 1. Ex Vivo Organ Perfusion Product Picture
Figure 2. Global Ex Vivo Organ Perfusion Market Share by Type: 2025 vs 2032
Figure 3. Heart Perfusion Features
Figure 4. Liver Perfusion Features
Figure 5. Kidney Perfusion Features
Figure 6. Lung Perfusion Features
Figure 7. Global Ex Vivo Organ Perfusion Market Share by Application: 2025 vs 2032
Figure 8. Organ Transplant Specialist Hospitals
Figure 9. Organ Banks
Figure 10. Pharmaceutical Research Organizations
Figure 11. Ex Vivo Organ Perfusion Report Years Considered
Figure 12. Global Ex Vivo Organ Perfusion Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Ex Vivo Organ Perfusion Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Ex Vivo Organ Perfusion Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Ex Vivo Organ Perfusion Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Ex Vivo Organ Perfusion Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Asia-Pacific Ex Vivo Organ Perfusion Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Latin America Ex Vivo Organ Perfusion Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Middle East & Africa Ex Vivo Organ Perfusion Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Global Ex Vivo Organ Perfusion Market Share by Players in 2025
Figure 21. Global Top Ex Vivo Organ Perfusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ex Vivo Organ Perfusion as of 2025)
Figure 22. The Top 10 and 5 Players Market Share by Ex Vivo Organ Perfusion Revenue in 2025
Figure 23. North America Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
Figure 24. North America Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
Figure 25. Europe Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
Figure 26. Europe Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
Figure 27. Asia-Pacific Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
Figure 28. Asia-Pacific Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
Figure 29. Latin America Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
Figure 30. Latin America Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
Figure 31. Middle East & Africa Ex Vivo Organ Perfusion Market Share by Type (2021-2026)
Figure 32. Middle East & Africa Ex Vivo Organ Perfusion Market Share by Application (2021-2026)
Figure 33. TransMedics Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 34. Lung Bioengineering Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 35. OrganOx Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 36. XVIVO Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 37. TNO Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 38. UHN Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 39. SCREEN Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 40. Bridge to Life Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 41. Organ Recovery Systems Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 42. Institut Georges Lopez Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 43. Ebers Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 44. Penn Medicine Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 45. Johns Hopkins Medicine Revenue Growth Rate in Ex Vivo Organ Perfusion Business (2021-2026)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed